Logo image of THRD

THIRD HARMONIC BIO INC (THRD) Stock Analyst Ratings

NASDAQ:THRD - Nasdaq - US88427A1079 - Common Stock - Currency: USD

5.17  +0.01 (+0.19%)

After market: 5.17 0 (0%)

Buy % Consensus

75

ChartMill assigns a Buy % Consensus number of 75% to THRD. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 4.67. This target is -9.71% below the current price.
THRD was analyzed by 11 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about THRD.
In the previous month the buy percentage consensus was at a similar level.
THRD was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
THRD Historical Analyst RatingsTHRD Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -29 -26 -23 -20 -17 -14 -11 -8 -5 -2 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 5.173.035.334.675.78 - -41.39% 3.18% -9.71% 11.70%
THRD Current Analyst RatingTHRD Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2025-03-28 Stifel Downgrade Buy -> Hold
2025-02-12 Morgan Stanley Downgrade Overweight -> Equal-Weight
2025-02-11 Raymond James Downgrade Outperform -> Market Perform
2024-08-09 Morgan Stanley Upgrade Equal-Weight -> Overweight
2024-06-18 Stifel Initiate Buy
2024-06-07 Raymond James Initiate Outperform
2023-08-11 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2022-12-16 Morgan Stanley Downgrade Overweight -> Equal-Weight
2022-12-16 Jefferies Downgrade Buy -> Hold
2022-10-10 Cowen & Co. Initiate Outperform
2022-10-10 Morgan Stanley Initiate Overweight
2022-10-10 Jefferies Initiate Buy